Medistim ASA (OSL:MEDI)
Norway · Delayed Price · Currency is NOK 256.00
+10.00 (4.07%)
Aug 24, 2026, 4:25 PM CET
Medistim ASA Financials Overview
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 752.84 | 699.77 | 562.6 | 521.11 | 486.26 | 417.82 |
Revenue Growth | 18.65% | 24.38% | 7.96% | 7.17% | 16.38% | 17.30% |
Gross Profit Gross Profit Growth | 608.69 | 571.59 | 448.92 | 408.83 | 379.78 | 320.7 |
Operating Income Operating Income Growth | 205.25 | 196.2 | 131.08 | 131.44 | 141.25 | 110.99 |
Net Income Net Income Growth | 165.3 | 159.21 | 103.83 | 103.82 | 113.97 | 90.9 |
Earnings Per Share EPS Growth | - | 8.71 | 5.67 | 5.67 | 6.24 | 4.98 |
EPS Growth | - | 53.63% | -0.01% | -9.13% | 25.30% | 31.05% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Growth | 66.26 | 62.27 | 61.34 | 64.37 | 61.1 | - |
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Growth | 39.34 | 40.73 | 39.5 | 36.24 | 32.69 | - |
Capital Sales - Flow Systems Capital Sales - Flow Systems Growth | 69.11 | 59.95 | 55.22 | 55.55 | 49.66 | - |
Capital Sales - Flow and Imaging Systems Capital Sales - Flow and Imaging Systems Growth | 130.65 | 119.13 | 69.17 | 81.49 | 86.43 | - |
Capital Sales - Flow Probes Capital Sales - Flow Probes Growth | 330.75 | 292.41 | 231.47 | 193.06 | 169.18 | - |
Capital Sales - Imaging Probes Capital Sales - Imaging Probes Growth | 26.82 | 24.05 | 16.08 | 16.23 | 17.04 | - |
Third Party Products Third Party Products Growth | 89.92 | 101.24 | 89.82 | 79.43 | 75.83 | 74.34 |
Revenue (Total) Revenue (Total) Growth | 752.84 | 699.77 | 562.6 | 526.36 | 491.94 | 427.28 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 100.15 | 212.09 | 179.21 | 153.87 | 152.64 | 129.49 |
Total Debt Total Debt Growth | 34.79 | 49.27 | 34.36 | 17.64 | 17.11 | 24.19 |
Net Cash (Debt) Net Cash Growth | 65.36 | 162.82 | 144.85 | 136.23 | 135.54 | 105.3 |
Net Cash Growth | -12.05% | 12.41% | 6.33% | 0.51% | 28.72% | 221.24% |
Net Cash Per Share Net Cash Per Share Growth | - | 8.91 | 7.91 | 7.45 | 7.42 | 5.77 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 185.65 | 187.08 | 143.1 | 119.2 | 113.49 | 127.37 |
Capital Expenditures CapEx Growth | -5.49 | -5.49 | -6.07 | -16.4 | -9.25 | -7.4 |
Free Cash Flow Free Cash Flow Growth | 180.16 | 181.59 | 137.04 | 102.8 | 104.24 | 119.97 |
Free Cash Flow Growth | 23.29% | 32.51% | 33.30% | -1.38% | -13.11% | 79.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 80.85% | 81.68% | 79.79% | 78.45% | 78.10% | 76.76% |
Operating Margin | 27.26% | 28.04% | 23.30% | 25.22% | 29.05% | 26.56% |
Pretax Margin | 28.46% | 29.56% | 23.86% | 25.95% | 30.04% | 27.30% |
Profit Margin | 21.96% | 22.75% | 18.46% | 19.92% | 23.44% | 21.76% |
FCF Margin | 23.93% | 25.95% | 24.36% | 19.73% | 21.44% | 28.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 8.000 | 8.000 | 6.000 | 4.500 | 4.500 | 3.750 |
Dividend Per Share Growth | 33.33% | 33.33% | 33.33% | 0% | 20.00% | 25.00% |
Dividend Yield | 3.38% | 3.20% | 4.31% | 2.32% | 2.18% | 1.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.33 | 29.74 | 26.37 | 37.68 | 36.99 | 73.64 |
Forward PE | 24.56 | 29.10 | 25.34 | 33.80 | 39.94 | 61.56 |
P/FCF Ratio | 25.99 | 26.08 | 19.98 | 38.05 | 40.45 | 55.79 |
PS Ratio | 6.22 | 6.77 | 4.87 | 7.51 | 8.67 | 16.02 |